Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:33 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
Soleus Private Equity Fund III L.P. | 3,994,629 8.700% |
3,994,629 (New Position) |
Filing History |
| 2024-11-14 3:32 pm Purchase |
2024-09-30 | 13G | Jasper Therapeutics, Inc. JSPR |
Soleus Private Equity Fund III L.P. | 1,343,665 9.000% |
1,343,665 (New Position) |
Filing History |
| 2024-11-14 3:32 pm Purchase |
2024-09-30 | 13G | CalciMedica, Inc. CALC |
Soleus Private Equity Fund III L.P. | 1,175,856 8.500% |
1,175,856 (New Position) |
Filing History |
| 2024-11-14 3:30 pm Sale |
2024-09-30 | 13G | Mereo BioPharma Group plc MREO |
Soleus Private Equity Fund III L.P. | 4,234,765 0.500% |
-44,652,330 (-91.34%) |
Filing History |
| 2024-10-28 4:00 pm Purchase |
2024-10-21 | 13G | Inhibikase Therapeutics, Inc. IKT |
Soleus Private Equity Fund III L.P. | 7,228,908 9.990% |
7,228,908 (New Position) |
Filing History |
| 2024-02-06 4:15 pm Purchase |
2023-12-31 | 13G | Mereo BioPharma Group plc MREO |
Soleus Private Equity Fund III L.P. | 48,887,095 7.000% |
500,000 (+1.03%) |
Filing History |
| 2024-02-06 4:15 pm Sale |
2023-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
Soleus Private Equity Fund III L.P. | 1,820,365 9.990% |
-47,690 (-2.55%) |
Filing History |
| 2024-01-10 09:00 am Purchase |
2024-01-08 | 13G | Immunic, Inc. IMUX |
Soleus Private Equity Fund III L.P. | 7,293,007 8.100% |
7,293,007 (New Position) |
Filing History |
| 2023-10-26 5:00 pm Purchase |
2023-10-25 | 13G | Harpoon Therapeutics, Inc. HARP |
Soleus Private Equity Fund III L.P. | 1,868,055 9.990% |
1,868,055 (New Position) |
Filing History |
| 2023-07-26 4:31 pm Purchase |
2023-07-24 | 13G | Mereo BioPharma Group plc MREO |
Soleus Private Equity Fund III L.P. | 48,387,095 7.500% |
48,387,095 (New Position) |
Filing History |
| 2023-05-24 4:31 pm Purchase |
2023-05-16 | 13G | InspireMD, Inc. NSPR |
Soleus Private Equity Fund III L.P. | 2,199,118 9.900% |
2,199,118 (New Position) |
Filing History |